ToFAcitinib in Early Active Axial SpondyloarThritis:

Conditions: Axial Spondyloarthritis Interventions: Drug: Tofacitinib 5 MG Sponsors: Charite University, Berlin, Germany; Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials